HAL vs XFOR · P/E 9.3, $19.05B cap vs rev $6.5M
Halliburton Company (HAL) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 154.2% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the HAL and XFOR stock pages for the full models.
Not investment advice.